Table 1 Comparison of baseline characteristics between dyslipidemia and normolipidemic groups

Male (n, %)

57

86

0.415

0.520

Age (years)

39.5 ± 11.9

40.9 ± 12.2

0.795

0.428

Combined therapy (n, %)

5

9

0.187

0.911

BMI (kg/m²)

25.0 ± 3.1

22.4 ± 2.2

5.428

0.000*

WBC (× 10⁹/L)

6.3 ± 2.1

5.6 ± 1.4

2.897

0.004*

NE%

0.6 ± 0.1

0.6 ± 0.1

0.138

0.890

NE(×10⁹/L)

3.7 ± 1.7

3.2 ± 1.2

2.586

0.011*

RBC(× 10¹²/L)

4.8 ± 0.6

4.8 ± 0.5

0.217

0.828

HB (g/L)

147.9 ± 15.7

145.5 ± 14.9

1.048

0.296

RDW (%)

13.4 ± 1.2

13.3 ± 2.8

0.158

0.875

PLT (×10⁹/L)

230.5 ± 78.5

215.2 ± 60.9

1.368

0.174

PT (s)

13.5 ± 0.8

13.4 ± 1

0.715

0.476

PTA (%)

92.2 ± 10.0

92.8 ± 13.3

0.341

0.733

INR

1 ± 0.1

1 ± 0.1

0.180

0.857

F (g/L)

3.1 ± 0.6

3.1 ± 0.9

0.398

0.691

APTT (s)

37.3 ± 4.2

36.8 ± 5.2

0.795

0.428

APTTR

1.0 ± 0.1

1.0 ± 0.2

0.140

0.889

TT (s)

17.1 ± 1.3

17.1 ± 1.5

0.175

0.862

TTR

1.0 ± 0.1

1.0 ± 0.1

0.228

0.820

TB (umol/L)

25.4 ± 58.9

15.1 ± 20.1

1.692

0.092

DBIL (umol/L)

15.3 ± 50.3

7.1 ± 18.1

1.502

0.135

TP (g/L)

75.5 ± 6.2

73.7 ± 6.6

1.889

0.061

A (g/L)

43.9 ± 5.6

44.4 ± 5.3

0.587

0.558

ALT (U/L)

349.1 ± 275.2

297.1 ± 224

1.314

0.191

AST (U/L)

249.1 ± 175

266.7 ± 175.9

0.830

0.408

ALP (U/L)

90 ± 22

84.1 ± 23.2

1.719

0.088

r-GT (U/L)

75.9 ± 56.6

72.5 ± 42

0.430

0.688

FBG (mmol/L)

5.3 ± 1.3

5.4 ± 1.6

0.697

0.487

BUN (mmol/L)

4.8 ± 1.4

4.5 ± 1.1

1.338

0.184

CR (mmol/L)

69.3 ± 12.5

67.6 ± 13.7

0.838

0.403

UA (umol/L)

379.9 ± 105

359.9 ± 99.4

1.257

0.211

TC (mmol/L)

5.5 ± 1.3

4.0 ± 0.7

10.210

0.000*

TG (mmol/L)

2.2 ± 0.8

1.1 ± 0.3

12.633

0.000*

HDL-C (mmol/L)

1.1 ± 0.4

1.1 ± 0.3

0.284

0.777

LDL-C (mmol/L)

3.4 ± 1.0

2.3 ± 0.7

8.574

0.000*

HBsAg S/CO

7557.4 ± 10,826.3

5377.3 ± 7487.7

1.494

0.137

HBeAg S/CO

901.5 ± 514.4

777.3 ± 512.9

1.567

0.119

HBV DNA Log₁₀IU/mL

7.4 ± 1.2

7.6 ± 1.1

1.114

0.267